Ascendis Pharma A (ASND) EBIT (2014 - 2026)
Ascendis Pharma A (ASND) reported EBIT of $256.26 million for the quarter ended Jun 30, 2026, compared with -$59.94 million a year earlier and up 782.2% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) EBIT (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's EBIT came in at $309.68 million; for the year ended Dec 31, 2025, it came in at -$153.96 million.
- By year, EBIT came in at -$301.72 million in the year ended Dec 31, 2024, -$492.77 million in the year ended Dec 31, 2023, -$592.13 million in the year ended Dec 31, 2022 and -$516.84 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly EBIT in data going back to the quarter ended Mar 31, 2014.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $29.05 million (quarter ended Mar 31, 2026), $11.52 million (quarter ended Dec 31, 2025) and $12.86 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 256.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256.26 Mn |
| Mar 31, 2026 | 29.05 Mn |
| Dec 31, 2025 | 11.52 Mn |
| Sep 30, 2025 | 12.86 Mn |
| Jun 30, 2025 | -59.94 Mn |
| Mar 31, 2025 | -109.62 Mn |
| Dec 31, 2024 | 409,272.04 |
| Sep 30, 2024 | -106.25 Mn |
| Jun 30, 2024 | -143.50 Mn |
| Mar 31, 2024 | -53.39 Mn |
| Dec 31, 2023 | -39.39 Mn |
| Sep 30, 2023 | -146.31 Mn |
| Jun 30, 2023 | -153.36 Mn |
| Mar 31, 2023 | -154.22 Mn |
| Dec 31, 2022 | -150.37 Mn |
| Sep 30, 2022 | -145.70 Mn |
| Jun 30, 2022 | -151.41 Mn |
| Mar 31, 2022 | -143.69 Mn |
| Dec 31, 2021 | -128.79 Mn |
| Sep 30, 2021 | -114.31 Mn |
API Access
Ascendis Pharma A EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();